PET Imaging of Breast Cancer: Role in Patient Management. Review uri icon

Overview

abstract

  • Breast cancer is the most common malignancy in females. Imaging plays a critical role in diagnosis, staging and surveillance, and management of disease. Fluorodeoxyglucose (FDG) PET the imaging is indicated in specific clinical setting. Sensitivity of detection depends on tumor histology and size. Whole body FDG PET can change staging and management. In recurrent disease, distant metastasis can be detected. FDG PET imaging has prognostic and predictive value. PET/MR is evolving rapidly and may play a role management, assessment of metastatic lesions, and treatment monitoring. This review discusses current PET modalities, focusing on of FDG PET imaging and novel tracers.

publication date

  • April 1, 2015

Research

keywords

  • Breast Neoplasms
  • Carcinoma, Ductal, Breast
  • Positron-Emission Tomography

Identity

Scopus Document Identifier

  • 84964311314

Digital Object Identifier (DOI)

  • 10.1016/j.cpet.2014.12.004

PubMed ID

  • 25829085

Additional Document Info

volume

  • 10

issue

  • 2